Policy Statement: Recommendations for the Prevention of Pneumococcal Infections, Including the Use of Pneumococcal Conjugate Vaccine (Prevnar), Pneumococcal Polysaccharide Vaccine, and Antibiotic Prophylaxis

Policy Statement: Recommendations for the Prevention of Pneumococcal Infections, Including the Use of Pneumococcal Conjugate Vaccine (Prevnar), Pneumococcal Polysaccharide Vaccine, and Antibiotic Prophylaxis

Item

http://www.wikidata.org/entity/Q29011885

Q29011885

about

Grommets (ventilation tubes) for recurrent acute otitis media in children Grommets (ventilation tubes) for recurrent acute otitis media in children Treatment Options for Primary Autoimmune Hemolytic Anemia: A Short Comprehensive Review Bacterial Infections Following Splenectomy for Malignant and Nonmalignant Hematologic Diseases Efficacy of pneumococcal immunization in patients with renal disease--what is the data?Splenectomy for chronic idiopathic thrombocytopenic purpura in children: a single center study in China.Current treatment options for primary immune thrombocytopenia.Guidelines on the treatment of primary immune thrombocytopenia in children and adolescents: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Guidelines Project: Associação Médica Brasileira - 2012 How I manage Evans Syndrome and AIHA cases in children.Antimicrobial resistance among isolates causing invasive pneumococcal disease before and after licensure of heptavalent conjugate pneumococcal vaccine Molecular epidemiology of pediatric pneumococcal empyema from 2001 to 2007 in Utah.Revised guidelines for management of steroid-sensitive nephrotic syndrome.Phenotypic and genetic diversity of invasive pneumococcal isolates recovered from French children.Active immunization in the United States: developments over the past decade.Nasopharyngeal carriage of antimicrobial-resistant Streptococcus pneumoniae among young children attending 79 kindergartens and day care centers in Hong Kong.Effect of pneumococcal conjugate vaccine on pneumococcal meningitis An epidemiological investigation of a sustained high rate of pediatric parapneumonic empyema: risk factors and microbiological associations.treatment and prevention of otitis media.Infections among long-term survivors of childhood and adolescent cancer: a report from the Childhood Cancer Survivor Study.Exposure to children as a risk factor for bacteremic pneumococcal disease: changes in the post-conjugate vaccine era.Global control of pneumococcal infections by pneumococcal vaccines Potential impact of conjugate vaccine on the incidence of invasive pneumococcal disease among children in Scotland Hospitalization for invasive pneumococcal disease in a national sample of children with sickle cell disease before and after PCV7 licensure.A bivalent vaccine based on a replication-incompetent influenza virus protects against Streptococcus pneumoniae and influenza virus infection.Mortality reductions for older adults differ by race/ethnicity and gender since the introduction of adult and pediatric pneumococcal vaccines Conjugated heptavalent pneumococcal vaccine.Increase in prevalence of Streptococcus pneumoniae serotype 6C at Eight Children's Hospitals in the United States from 1993 to 2009.Vaccine production, distribution, access, and uptake.Pneumococcal conjugate vaccine: economic issues of the introduction of a new childhood vaccine.Pathological basis of symptoms and crises in sickle cell disorder: implications for counseling and psychotherapy Management of sickle cell disease in primary care.Invasive pneumococcal disease among children with and without sickle cell disease in the United States, 1998 to 2009.Applying the bacterial meningitis score in children with cerebrospinal fluid pleocytosis: a single center's experience.Comparative analysis of the humoral immune response to Moraxella catarrhalis and Streptococcus pneumoniae surface antigens in children suffering from recurrent acute otitis media and chronic otitis media with effusion.Endocarditis with ruptured sinus of Valsalva aneurysm caused by nonvaccine Streptococcus pneumoniae serotype 21.Vaccination considerations in the asplenic patient.Nasopharyngeal Pneumococcal Carriage among Healthy Children in Cyprus Post Widespread Simultaneous Implementation of PCV10 and PCV13 Vaccines.Pediatric invasive pneumococcal disease in the United States in the era of pneumococcal conjugate vaccines.Safety and Immunogenicity of Human Serum Albumin-Free MMR Vaccine in US Children Aged 12-15 Months.Pneumococcal Colonization Rates in Patients Admitted to a United Kingdom Hospital with Lower Respiratory Tract Infection: a Prospective Case-Control Study.

P2860

Q24241357-8792C950-2ED3-4157-95A5-79533EF6020E Q24247317-EE38C4CE-E554-4602-96BE-437254DA8889 Q26773178-ECCD31AD-B256-4E3C-B518-B96D333ABE3C Q26778773-B31FA9AB-16E6-428F-AE74-8FA9133ABE54 Q30947054-1BB751D6-0E8B-41FE-8BFA-94BB12FCDF2C Q33369981-B3F96B6F-78D1-4871-9B9E-5517215D4034 Q33394149-241B03C6-F5EE-48D2-9F2C-DB0616330926 Q33413038-D38B47C0-5218-4962-A351-F1177FB1F055 Q33428041-D65941FF-F264-41A2-886D-09EE79B1F2E9 Q33470299-21C5DC1A-B54F-4A77-82EC-ACC731BEB401 Q33627308-17A30FCE-427E-4DF3-B376-0FBD07E7CFFA Q33762358-CDDE579E-56F6-4C36-A21E-AEF278849FFC Q33964352-ED3E034D-220F-422F-A88B-7BEFC871A797 Q33975799-276C97B6-5E67-4685-9B49-14AD6E3CBE1A Q33983099-FD06089E-0A6B-433B-A72E-1CE1B22B80DE Q34015633-8CEADC51-BAB6-4C4E-AB46-38A545B75733 Q34109967-1EA98DA9-98D6-420D-ABBF-782212A3FDAA Q34122529-D8CC9901-B0ED-4151-A449-120E619D2D4D Q34155833-DAB7B68F-703B-4570-A3C7-AC2F2FFAB07B Q34157622-5B360CA8-D220-46C6-BFE2-506CED87F210 Q34375742-42C7DFE7-64BA-48F7-943E-FDC7CA5DF9A7 Q34569142-FB4691D0-7B5F-4D02-ADC1-C0C58C167C7D Q34591762-473CA301-5CF6-43C6-825C-8412A0E14133 Q34594671-4BFAD980-F359-4A5C-848C-1D3BCBEC7375 Q34663884-2341A777-DF3B-4699-9814-284DB8174B28 Q34796973-1F9450FF-78DD-4C56-B0A2-F56D7888FB1A Q35066883-07850C02-56B9-4069-8B0D-4DA4EC3470D7 Q35188985-CF0449F5-C737-4645-936F-2796F50C6AD5 Q35195925-C99BA420-3172-49AA-BC77-6116D2809E76 Q35567943-8CBB3B38-905B-4426-BDE8-6934B1F5007C Q35611782-D3E5994D-2D48-4B38-8215-53E01206A03D Q35902336-B18BFBB7-8F15-4E25-B64F-AD38BE4AEEC5 Q35976434-39F746EC-40C5-4CD2-9FCE-085C63DDFB0D Q36017775-CFEBE96C-7E3A-4EBB-8840-CD954DCEE8DC Q36061043-680EF30C-9DF3-4E13-AF05-E7B43BDA293D Q36066242-5A2E2FCF-D8B6-44B7-8F5E-22E81CA698F1 Q36153943-859A1C35-5126-415E-8607-27DFD24A3D4C Q36156085-3DC88B6F-0B11-434D-9346-57BEB64FE02C Q36377372-382AC8EC-4ED0-4320-9F32-954F522CDB2A Q36734938-F97C0FB5-F834-4F5F-A5BB-C22181DC6E2B

P2860

Policy Statement: Recommendations for the Prevention of Pneumococcal Infections, Including the Use of Pneumococcal Conjugate Vaccine (Prevnar), Pneumococcal Polysaccharide Vaccine, and Antibiotic Prophylaxis

Item

http://www.wikidata.org/entity/Q29011885

description

2000 nî lūn-bûn

@nan

2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu